[{"uuid": "45bccb20-268d-3075-a01b-a9521d2dfc3a", "title": "BMY Gets Positive CHMP Opinion for Opdivo, Yervoy Combo and Breyanzi", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bmy-gets-positive-chmp-opinion-183400618.html", "providerPublishTime": 1738607640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SlGE5JR4xp73Vb5zTu29cQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iAjYTqhtpV3hPzryhmSe_g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "d86cb7e9-c3ff-33e3-be48-53717638e359", "title": "Should Bristol Myers Stock Be in Your Portfolio Pre-Q4 Earnings?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bristol-myers-stock-portfolio-pre-153700544.html", "providerPublishTime": 1738597020, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0.VF5p.GUKhgU24gMni2XA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WxCEtCRmq3N_hZOUME3zRA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "6453d52a-2535-3fb8-9366-5a8900b80fe5", "title": "The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-092300966.html", "providerPublishTime": 1738660980, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/IW5EhxEFuSd4V4nUFOhT_A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/AxvgHTECT_FnPZu0GsWG_A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT", "PFE", "LLY", "AMGN", "MRK"]}, {"uuid": "194ad646-67e3-3dbd-a392-173208227673", "title": "What Analyst Projections for Key Metrics Reveal About Bristol Myers (BMY) Q4 Earnings", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/analyst-projections-key-metrics-reveal-141609402.html", "providerPublishTime": 1738592169, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/9tpS8u8rAmiEoUItmUZeOA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pDKsOs.OZIPdDtC_zqOnWw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/090f58c1efbe3555b861102525e50b39", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "a59ebf2c-0769-3750-98b2-a5c5f03465ec", "title": "Jim Cramer on Bristol-Myers Squibb Company (BMY): \u2018With That Yield, It\u2019s One Of My Faves\u2019", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/jim-cramer-bristol-myers-squibb-153949041.html", "providerPublishTime": 1738597189, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/en44qJadwHtgnjLpOOwvDg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/g1bbtdAPuh9IQvVXGINP7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT", "^GSPC"]}, {"uuid": "a273dd96-9314-390c-9f38-a073de2c410e", "title": "Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/5-big-drug-stocks-surpass-162000365.html", "providerPublishTime": 1738599600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gw9hjYsV9oVXUgeEGEfgLQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ecnM_GSyzlN5rf_uf5pFog--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["LLY", "PFE"]}, {"uuid": "24ba4c18-3e06-3f6f-9f27-1ccf1f6b7283", "title": "2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond", "publisher": "Motley Fool", "link": "https://finance.yahoo.com/m/24ba4c18-3e06-3f6f-9f27-1ccf1f6b7283/2-high-yield-dividend-stocks.html", "providerPublishTime": 1738589520, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/8vGsaA6I9u1CnTLqUNGzUA--~B/aD0xNDE0O3c9MjEyMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/31b61f7086f0e4a93bc6324505b54e39", "width": 2121, "height": 1414, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0G8oU8ncKgZ0Bzm_E45gNw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/31b61f7086f0e4a93bc6324505b54e39", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NVS", "CELG-RT"]}, {"uuid": "55b62558-f288-33b8-92c5-12b3d199eaea", "title": "Incyte (INCY) Earnings Expected to Grow: Should You Buy?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/incyte-incy-earnings-expected-grow-150021053.html", "providerPublishTime": 1738594821, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XFzKRSTb2_xUaLSOCP9.Bg--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c", "width": 900, "height": 602, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/UF5vS9CCA_LIuCo4lg9rzA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["INCY", "CELG-RT"]}, {"uuid": "bd9b0f2c-3319-44c7-9041-383deea058cb", "title": "Trump tariffs, more Big Tech earnings, and a jobs report: What to know this week", "publisher": "Yahoo Finance", "link": "https://finance.yahoo.com/news/trump-tariffs-more-big-tech-earnings-and-a-jobs-report-what-to-know-this-week-125025891.html", "providerPublishTime": 1738500625, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cED2mqgtOOmTuVmsdmu0VQ--~B/aD0zNjY4O3c9NTUwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-01/549d2d70-dfe0-11ef-bbff-7c4ffd69755f", "width": 5500, "height": 3668, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/nax0KIE4XxTPruH.4tgOtw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/os/creatr-uploaded-images/2025-01/549d2d70-dfe0-11ef-bbff-7c4ffd69755f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AMZN", "^SPX", "CMG", "GOOG", "QQQ", "^DJI", "^IXIC", "^GSPC", "LLY", "SPY"]}, {"uuid": "fb9532d6-557a-3dba-95ef-f8c7dbc7b864", "title": "What To Expect in the Markets This Week", "publisher": "Investopedia", "link": "https://finance.yahoo.com/m/fb9532d6-557a-3dba-95ef-f8c7dbc7b864/what-to-expect-in-the-markets.html", "providerPublishTime": 1738490400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xoQQ3n8Owb3jgA8Pr3MRWQ--~B/aD0zMzMzO3c9NTAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/958fc9f3c8b7a6a27e65730e75ff296b", "width": 5000, "height": 3333, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I6rgoXW8.zVlZoxaTHpHbg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/investopedia_245/958fc9f3c8b7a6a27e65730e75ff296b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GOOG", "LLY", "NVO", "AMD", "PLTR", "AMZN"]}, {"uuid": "5ab9357f-263e-3cd2-96b2-8433f335583f", "title": "Why Bristol-Myers Squibb Company (BMY) Is Among the Best Long Term Low Risk Stocks to Buy Now", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-bristol-myers-squibb-company-082004733.html", "providerPublishTime": 1738398004, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/en44qJadwHtgnjLpOOwvDg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/g1bbtdAPuh9IQvVXGINP7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "f4207446-5517-3071-911f-571cf265186a", "title": "No One Knows How to Price AI Tools", "publisher": "The Wall Street Journal", "link": "https://finance.yahoo.com/m/f4207446-5517-3071-911f-571cf265186a/no-one-knows-how-to-price-ai.html", "providerPublishTime": 1738414800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Fwf5HL4GsEGPbDfR3MJBPg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 1200, "height": 630, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/zIJaagDuCJitt1Cvcwyc7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMY", "CELG-RT", "MSFT", "CRM", "PFG", "UAL", "AMZN"]}, {"uuid": "6b84cb75-75cb-33a2-9c9f-f9f81fb1c9ef", "title": "Best value ETFs: Top funds that hold bargain-priced stocks", "publisher": "Bankrate", "link": "https://finance.yahoo.com/news/best-value-etfs-175400012.html", "providerPublishTime": 1738387200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ansO6Fi6iUNyW3WqmI4LwQ--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bankrate_626/7618ab6fa9e3791e04e4ab6b127594bb", "width": 1280, "height": 720, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pxUnog4e2PLBelEBoRZMLg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bankrate_626/7618ab6fa9e3791e04e4ab6b127594bb", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "f13f427d-86fe-32c4-9e51-efca9f7f69ab", "title": "Bristol-Myers Squibb Says EU Regulator Panel Recommends Liver Cancer Treatment for Approval", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-says-eu-124246771.html", "providerPublishTime": 1738327366, "type": "STORY", "relatedTickers": ["CELG-RT"]}, {"uuid": "e58f9bcb-c456-3710-ba9b-5d4b1ef8de72", "title": "Bristol-Myers Squibb Says EU Panel Recommends Breyanzi's Approval for Follicular Lymphoma", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-says-eu-123719119.html", "providerPublishTime": 1738327039, "type": "STORY", "relatedTickers": ["CELG-RT"]}, {"uuid": "42519aaa-ca3d-3dc0-9c97-5e87379d2ff1", "title": "Earnings Calendar, Analyst Estimates And Stocks To Watch", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/42519aaa-ca3d-3dc0-9c97-5e87379d2ff1/earnings-calendar%2C-analyst.html", "providerPublishTime": 1738360291, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/1Lee44kFd55pxBMgXaLP6g--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/efe923ca55d6d3ef08ab25c1eb1df45a", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/.mF88dpmtPOzaeL8BKi6og--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/efe923ca55d6d3ef08ab25c1eb1df45a", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "31630965-cf1b-39a1-9c1d-ce0ced3c4044", "title": "Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo\u00ae (nivolumab) plus Yervoy\u00ae (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-receives-positive-115900977.html", "providerPublishTime": 1738324740, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JRtyzBadqE1Nq.uHIWMUwQ--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9d41d7dd6df6bd90003c55184674f52d", "width": 1497, "height": 206, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WJy8uojPrXdfK6vNe_ylZw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/9d41d7dd6df6bd90003c55184674f52d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMY", "CELG-RT"]}, {"uuid": "94ed26c0-765f-3182-a6b5-c8e8ff0d65bb", "title": "Bristol Myers Squibb (BMY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-expected-150110943.html", "providerPublishTime": 1738249270, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ksLAzii1aL14haHFbPC1Rg--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/sz.PXkOG_KtvLQskImJYTA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT", "QGEN"]}, {"uuid": "d6ed3b5d-72e1-3e72-a8a6-8e275c08df93", "title": "Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/bristol-myers-bmy-beat-estimates-171006780.html", "providerPublishTime": 1738257006, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/YliGu3uiWo7T6YkWQuaEpA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4", "width": 900, "height": 601, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7CzRl1qWfIp6OHUqiEloWA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CELG-RT"]}, {"uuid": "5d93afcc-9d8f-357e-b270-c6cfcedcc139", "title": "Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/bristol-myers-squibb-receives-positive-115000051.html", "providerPublishTime": 1738324200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/X1XZjtp3.8W4t0XI212Cww--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e537ab1f7e5630f8a346fa47e815c237", "width": 1497, "height": 206, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dBnuASarD5_akAk0yI6mYg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e537ab1f7e5630f8a346fa47e815c237", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BMY", "CELG-RT"]}]